Lithium therapy and signal transduction

Trends in Pharmacological Sciences

Volumn 21, Issue 2, 2000, Pages 61-64

  Williams, Robin S B ^a   Harwood, Adrian J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INOSITOL 1,4,5 TRISPHOSPHATE; LITHIUM; PEPTIDASE;

ALZHEIMER DISEASE; DEPRESSION; DRUG MECHANISM; HUMAN; PATHOGENESIS; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034141704     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01428-5     Document Type: Note

References (35)

1. Hammond W.A. Insanity. A Treatise on Diseases of the Nervous System. 1873;381 D. Appleton, New York.
2. Lenox R.H.et al. Neurobiology of lithium: an update. J. Clin. Psychiatry. 59:1998;37-47.
3. He X.et al. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature. 374:1995;617-622.
4. Harwood A.J.et al. Glycogen synthase kinase 3 regulates cell fate in Dictyostelium. Cell. 80:1995;139-148.
5. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8455-8459.
6. Stambolic V.et al. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6:1996;1664-1668.
7. Ryves W.J.et al. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts. Anal. Biochem. 264:1998;124-127.
8. Lijam N.et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell. 90:1997;895-905.
9. Grahame-Smith D.G. Disorder of synaptic homeostasis as a cause of depression and a target for treatment. Briley M., Montgomery S. Antidepressant Therapy. 1998;111-140 Martin Dunitz.
10. Cotter D.et al. Abnormalities of Wnt signalling in schizophrenia - evidence for neurodevelopmental abnormality. NeuroReport. 9:1998;1379-1383.
11. Lucas F.R., Salinas P.C. WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 192:1997;31-44.
12. Lucas F.R.et al. Inhibition of GSK-3β leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J. Cell. Sci. 111:1998;1351-1361.
13. Goold R.G.et al. Glycogen synthase kinase 3β phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. J. Cell Sci. 112:1999;3373-3384.
14. Lee G.et al. Tau interacts with src-family non-receptor tyrosine kinases. J. Cell Sci. 111:1998;3167-3177.
15. Hong M.et al. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272:1997;25326-25332.
16. Lovestone S.et al. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. Biol. Psychiatry. 45:1999;995-1003.
17. Yuan P.X.et al. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Brain Res. Mol. Brain Res. 58:1998;225-230.
18. Fiol C.J.et al. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J. Biol. Chem. 269:1994;32187-32193.
19. Kovacs D.M., Tanzi R.E. Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations. Cell. Mol. Life Sci. 54:1998;902-909.
20. Wolfe M.S.et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 398:1999;513-517.
21. Duff K.et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
22. Hanger D.P.et al. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localization of the kinase. Neurosci. Lett. 147:1992;58-62.
23. Takashima A. Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9637-9641.
24. Kang D.E.et al. Presenilin 1 facilitates the constitutive turnover of β-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the β-catenin-signaling pathway. J. Neurosci. 19:1999;4229-4237.
25. Berridge M.J.et al. Neural and developmental actions of lithium: a unifying hypothesis. Cell. 59:1989;411-419.
26. Einat H.et al. Augmentation of lithium's behavioural effect by inositol uptake inhibitors. J. Neural. Transm. 105:1998;31-38.
27. Acharya J.K.et al. Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants. Neuron. 20:1998;1219-1229.
28. Williams R.S.et al. Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J. 18:1999;2734-2745.
29. Maes M.et al. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res. 58:1995;217-225.
30. Maes M.et al. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol. Psychiatry. 35:1994;545-552.
31. Cunningham D.F., O'Connor B. Proline specific peptidases. Biochim. Biophys. Acta. 1343:1997;160-186.
32. Kato T.et al. Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Mol. Cell Biochem. 32:1980;117-121.
33. Toide K.et al. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats. Pharmacol. Biochem. Behav. 56:1997;427-434.
34. Cook L.L., Persinger M.A. 'Subclinical' dosages of lithium and pilocarpine that do not evoke overt seizures affect long-term spatial memory but not learning in rats. Percept. Mot. Skills. 86:1998;1288-1290.
35. Hartigan J.A., Johnson G.V. Transient increases in intracellular calcium result in prolonged site- selective increases in Tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway. J. Biol. Chem. 274:1999;21395-21401.